New York State Common Retirement Fund’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

New York State Common Retirement Fund’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-27,257	Closed	-$182K	–	3269
2023 Q3	$182K	Buy	27,257 +299	+1%	+$2.48K	﹤0.01%	2473
2023 Q2	$244K	Sell	26,958 -12,476	-32%	-$110K	﹤0.01%	2405
2023 Q1	$287K	Sell	39,434 -12,906	-25%	-$95.7K	﹤0.01%	2443
2022 Q4	$382K	Sell	52,340 -22	-0%	-$163	﹤0.01%	2445
2022 Q3	$405K	Buy	52,362 +662	+1%	+$5.62K	﹤0.01%	2445
2022 Q2	$352K	Buy	+51,700	New	+$396K	﹤0.01%	2522

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

New York State Common Retirement Fund's PNT Position: Q4 2023 in Review

New York State Common Retirement Fund sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 27,257 shares — an estimated $182K sold.

New York State Common Retirement Fund first reported a position in PNT in Q2 2022 and held it in 6 quarters. The position peaked at $405K in Q3 2022. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

New York State Common Retirement Fund reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 27,257 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $182K.
New York State Common Retirement Fund first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2022 and held it in 6 quarters.
New York State Common Retirement Fund's POINT Biopharma Global Inc. Common Stock position peaked at $405K in Q3 2022.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on New York State Common Retirement Fund's 13F filing for Q4 2023, filed 1 Feb 2024.